About Conference

Metabolomics and Systems Biology extends the heartiest welcome to
proficient delegates, scientists, professors, students, young researchers,
business executives, scholars, chemists and professionals across the globe to
be a part of “International
Congress on Metabolomics and Systems Biology”on May 22-23, 2019, to be held at Tokyo, Japan.Keynote speech, exhibitions, oral and poster presentations outline the
key attractions of the conference on the theme "To Encompass Emerging Trends in Metabolomics and Systems Biology."

Allied Academiesis one of the leading
Open Access publishers and organizers of international scientific conferences
and events every year across USA, Europe & Asia. Allied Academies has so
far organized 3000+ Global Allied Academies. Events with over 600+ Conferences,
1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science,
Technology and Business with 700+ peer-reviewed open access journals in basic
science, health, and technology.

We are pleased to invite you to join us at the International Congress on
Metabolomics and Systems Biology 2018, where you will be sure to have a
meaningful experience with scholars from around the world. All members of the
organizing committee look forward to meeting you in Lisbon, Portugal.

Welcome Message

Allied Academics Publication is an amalgamation of several esteemed academic and
scientific associations known for promoting scientific
temperament. Established in the year 1997, the conferences provide a
global platform for the attendees to showcase their research and services in front of many key
players in the field. test

Metabolomics Congress 2019aims to bring together the prominent
researchers, academic scientists, and research scholars to exchange and share
their experiences on all aspects of Metabolomics. It is also an
interdisciplinary platform for researchers, practitioners and educators to
present and discuss the most recent advances, trends, and concerns as well as
practical challenges and solutions adopted in the fields of Metabolomics and
Systems Biology.

Sessions/Tracks

Track 1: Bio
transformations & Xenobiotics

Biotransformation is the process that metabolize substances entering the
body, such as drugs. It is the metabolic conversion of xenobiotic and
endogenous chemicals to more water-soluble compounds. It is also known as
Detoxification reaction. Generally, the physical properties of a xenobiotic are
changed from lipophilicity (absorption) to hydrophilicity (excretion). Xenobiotic biotransformation
is accomplished by a limited number of enzymes with broad substrate
specificities. Lipid soluble drugs are poorly excreted in the urine. They
tend to store in fat and/or circulate until they are converted (phase I biotransformation)
to more water soluble metabolites or metabolites that conjugate (phase II
biotransformation) with water soluble substances. Xenobiotics are
biotransferred through any of the following reactions: Oxidation (Drugs, heavy
metals), Reduction (Cosmetic Chemicals, heavy metals) and Hydrolysis
(Drugs).

Microbial bio
transformations

Metabolic
engineering and biocatalytic applications

Metabolomics as
a global biochemical approach to drug response and disease

Challenges and
Opportunities of xenobiotics in metabolomics

Profiling the
reactive metabolites of xenobiotics using metabolomic technologies

Track 2: Metabolomic studies

Metabolomics is the scientific study of chemical processes involving metabolites. Specifically,
metabolomics is the "systematic study of the unique chemical fingerprints
that specific cellular processes leave behind", the study of their
small-molecule metabolite profiles. Metabolomics is the simultaneous
('multiparallel') measurement of the levels of a large number of cellular
metabolites. The emerging field of
metabolomics had profound importance in recent years as its wide applications
in the field of drug discovery and drug development. In the
agricultural/chemical industry, metabolomics may be used to develop herbicides
and pesticides.

Metabolomics studies identifies metabolites for early diagnosis of
disease. Obesity is becoming a major health concern in the world. Metabolic syndrome(MS) is a disease with complex pathological condition and
pathogenesis involving multiple systems of the human body. Metabolomic
syndrome is characterized with central obesity, hyperglycemia, hyperlipidemia, hypertension, hyperuricemia, and
abnormal aggregation of other metabolic components . Metabolomicsprovides molecular information for understanding pathogenesis
and has been playing an important role in unravelling the pathophysiology and
identifying early biomarkers of specific physiological responses of complex
human diseases in particular metabolomic syndrome.

Metabolic and
endocrine science

Metabolomics in
obesity

Metabolomics in
diabetes

Metabolomics in
neuroscience and neurology

Metabolomics in
cardiovascular diseases

Metabolomics
and traditional medicine study

Dietary
patterns in Metabolic syndrome

Genomics of
paediatric metabolic syndrome

Track 4: Cancer Metabolomics

Cancer is
a devastating disease that alters the metabolism of a cell and the surrounding
milieu. Metabolomics has
a great and largely untapped potential in the field of oncology and the
analysis of the cancer metabolome to identify biofluid markers and druggable
targets. The recent studies in metabolomics have a better understanding
of metabolismof
cancer and how cancer cells use glycolysis, known as the“Warburg effect,” to produce the nucleotides, lipids and amino acids
necessary for tumour proliferation and vascularization. Recently Metabolomics
research discover diagnostic cancer biomarkersin the clinic, to discover pathways involved in cancer, to
monitor metabolic biomarkers during therapeutic intervention and to understand
its complex heterogeneous nature for new targets.

Role of NMR
based metabolomics in Cancer

Cancer
metabolism meets systems biology

Gene therapy

Active
immunotherapies

Cancer
immunotherapy

Metabolic
profiling in cancer

Applications
of metabolomics in oncology

Applications
of metabolomics in oncology and biomarker discovery

Metabolite
platform for robust validation of biomarkers

Track 5: Plant and
Environmental Metabolomics

To
characterise at sub atomic level of the metabolomeof plants
under particular conditions is known as plant Metabolomics. Environmental metabolomicsis the application of metabolomics that have enabled the
interactions of organisms with their environment. This approach has many
advantages for studying organism–environment interactions and for assessing
molecular level of organism function and health. Terrestrial life necessitated
a substantial increase in the capacity and generality with environmental Xenobiotics,
including compounds present in food. It implies for bioaccumulation,
monitoring of environmental Xenobiotics, toxicity of select chemicals,
persistence and residue dynamics. As such, metabolomics is finding an
increasing number of applications in the environmental sciences, ranging from
understanding organismal responses to abiotic pressures, to investigating the
responses of organisms to other biota. Metabolomicsis used for understanding relation between genes and the
biochemical composition of a plant in response to its environment can be
obtained, and this information can be further used to assess gene
function..

Metabolomics
for exposomics

Toxicology
and drug metabolism

Plant
metabolic network

Application
of LC-MS in plant metabolomics

Nutrigenomics
and plant functional genomics

Environmental
metabolome

Green
systems biology

Metabolomics
of genetically modified crops

Microbiome-related
metabolome

Track 6: Nutritional
metabolomics

The study of nutritional metabolomics is also known
as Edibilomicsand is a multi-disciplinary science. It analyses
metabolites in biological samples for a better understanding of biological
mechanisms underlying the impact of diet on human health and disease and to
facilitate molecular phenotyping for development of personalized nutritionstrategies. It provides biologicalinsights that reflect physiological and
disease-induced biological states at the molecular level, considering genetic factors,
the effects of environmentalexposures and health status. e.g., diet,
medication, environmental contaminants and other lifestyle factors.

Metabolomics
of genetically modified crops

Metabolomics in nutrition research

Dietary
metabolites and cellular metabolism

Nutrigenomics
and plant functional genomics

Food
safety and contamination assessment using metabolomics

Emerging
role of metabolomics in human nutrition

Track 7: Food and Drug delivery systems

Foodomics contains the combination of
biological sciences, food chemistry and data analysis. The food metabolomics is
also known as foodomics. Food-omics applications include the genomic,
transcriptomic, proteomic, metabolomics, study of foods for compound profiling,
authenticity, biomarker-detection related to food quality or safety and the
development of new transgenic foods. Recently food-omics have
enabled nutrition and food domains through the application of advanced omics
technologies in which Mass spectroscopytechniques are considered necessary. Researches are being done to
understand the effects of gene-food interaction on human health (Nutrigenomics).With the help of systems biology research, nutrigeneticsdescribes the whole body responds to
food. New drug delivery approaches have been receiving significant attention.
Metabolomics play a vital role in the prediction of drug’s effects on the body
by explaining the mechanisms by which drug response causes adverse effects.

Food
Metabolome

Food and
nutritional metabolomics

Applications
of metabolomics to food processing

Potential
of Diagnosis and Biomarkers

Drug
Target Identification and Validation

ADMET
Screening

Challenges
of Pharmetabolomics

Applications
in Clinical Studies

Track 8: Analytical and Bio-Analytical Techniques in
Metabolomics

Metabolomics is
the relative analysis of endogenous metabolites and to identify and quantify
metabolites from a biological sample. Metabolitesrepresent various groups of low molecular weight structures
including lipids, amino acids, peptides, nucleic acids, organic acids,
vitamins, thiols and carbohydrates, which makes global analysis a tiresome
challenge. The rapid development of analytical platforms, includingGC, HPLC, UPLC, CE coupled to MS and NMR spectroscopy,could enable separation, detection, characterization and
quantification of such metabolites and related metabolic pathways. To detect
all metabolites in a biological sample, the complexity of themetabolome and
the miscellaneous properties of metabolites has no single analytical platform
can be applied. By single analytical technique, the integrated use of modern
instrumental analytical approaches is beneficial to increase detected
metabolites that cannot be achieved. These analytical platforms have been
frequently used to provide tactful and valid detection of metabolites in a
biofluid sample. Continuous development of these analytical platforms will
accelerate widespread use and incorporation of metabolomics into systems
biology.

Translational
biomarker discovery

Nuclear
magnetic resonance (NMR)

Mass
spectrometry

Ratio
analysis of NMR/MS

Analytical
variability and issues

Chromatographic
methods in metabolomics

GC/MS,
LC-MS, CE/MS based metabolomics

MALDI
mass spectrometric imaging

Metabolite
extraction

Metabolomics
screening

NMR
fingerprinting, profiling

Track 9: Computational
Methodologies and systems biology

Computational methodologiesendeavours to study, analyse and understand
complex biological systems by taking a corresponding integrated systems. Systems biology and metabolomics is the ultimate phenotyping as it opens up the possibility
of studying the effect of complex mixtures. Recent advances in ‘-omics’ technologies
and the development of new computational techniques and algorithms have greatly
contributed to progress in metabolomics. Computational metabolomics and to highlight the similarities,
differences and areas of convergence between metabolomics, genomics, proteomics
and transcriptomics. Recent progress being made in four key areas of
computational metabolomics: (i) metabolomics databases; (ii) metabolomics LIMS
and data standards; (iii) spectral analysis tools for metabolomics and (iv) metabolic modeling. Some of the newly emerging computational strategies in
metabolomics that are being used to aid in the identification of metabolites
from biofluid mixtures analyzed by NMR and MS.

Systems
biology methods to characterize biological systems

Knowledge
discovery and data mining techniques

Machine
learning and pattern recognition

Sequence
motifs and alignments

Hidden
markov model

Sequencing
algorithms

Bioinformatics
and cheminformatics

Stochastic
modelling

Track 10: Clinical and
Precision Medicine Metabolomics

Metabolomics is
being used to interpret disease mechanisms, diagnose disease, recognize novel
drug targets, improve drug treatments and monitor beneficial outcomes.
Treatment decisions are based on the clinical stage of disease but fail to
ascertain the individual ´s underlying biology and its role in driving malignancy. The identification of better therapies is thus limited by the
lack of sufficient data regarding the characterization of specific biochemical
signatures. Metabolomics approaches promise a better understanding of a
disease characterized by significant alterations in bioenergetic metabolism, by
identifying changes in the pattern of metaboliteexpression in addition to changes in the concentration of
individual metabolites as well as alterations in biochemical pathways. These
approaches hold the potential of identifying novel biomarkers with different
clinical applications. Translational BiomarkerDiscovery Core fuse recognizing, supporting and making
pre-clinical biomarkers for working up the region of illness. The new field
of precision medicine is transforming current medical practice and even
reshaping future medicine.

Regenerative
medicine and predictive medicine

Inborn
errors of metabolism (IEM)

Nutraceuticals

Pharmacometabolomics
and precision medicine

Precision
medicine for mental disorders

Clinical
applications of metabolomics in diabetes treatment

Clinical
risk prediction using metabolomics

Personalized
medicine

Metabolomics
in clinical pharmaceutical R&D

Track 11: Diagnostic Biomarkers
in Metabolomics

Metabolomics has been devoted to search for
biomarkers that can be used for diagnosis and prognosis of malignant tumors.
A biomarkerreveals further information to presently
existing clinical and pathological assessment. It facilitates screening and
detecting the disease, monitoring the progression of the disease, and
predicting thediagnosis and survival after clinical intervention. Biomarker can be used to upgrade the
efficacy of disease treatment by enabling physicians to customize treatment for
individual patients. These emerging biomarkers will be advantageous and
critical in developing clinically valid indicators that will have a high
specificity for the diagnosis. The utility of the biomarker set from a complex
multivariate analysis to a binary format applicable for transformation to a
field-based diagnostic, validating the use of complex data miningtools applied to infectious disease
biomarker discovery and diagnostic development is extended by machine learning.

Metabolomics
in biomarker discovery

Metabolite
platform for validation of biomarkers

Biomarkers
in drug development

Disease related
biomarkers

Imaging
biomarkers

Track 12: Clinical Metabolomics And Lipidomics

Metabolomics,including the subfield of lipidomics, involve the analysis of endogenous biomolecules in complex
biological matrices. Lipids are the important
participant in control and regulation of cellular function. The range of
chemical structure of these lipids is a major challenge for managing high
volumes of compound data. Lipidomics is a growing field with numerous
applications for analysing different cell types. Identification of lipid
composition and quantification of cellular lipids gives us details about the
lipid related pathway which also helps in identification of metabolic pathways
and the effected enzymes. Metabolomics and lipidomics, pronounced mechanical
assemblies in systems science, screening little metabolites present in natural
illustrations. Contrasts in the species or measures of metabolites can be used to depict
phenotypes and common responses to inconveniences.

Molecular
biological profiling

Translational
biomarker discovery

Metabolic
interactions

Clinical
applications of metabolomics

Metabolomics
and mass spectrometry

Mass spec
in Clinical Microbiology

Forensic
analysis

Track 13: Metabolic Modelling
and Synthetic Biology

Synthetic biology will revolutionize how we conceive
and approach the engineering of biological systems. The vision and applications
of this emerging field will influence many other scientific and engineering
disciplines, as well as affect various aspects of daily life and society. This
aims to create novel biological functions and systems not found in nature by
combining biology with engineering. The workflow of the development of novel
cell factories with synthetic biology is ideally linear which will be
attainable with the quantitative engineering approach, high-quality predictive
models, and libraries of well-characterized parts. Many metabolitesand enzymes, metabolic models, metabolism and its components are useful in
synthetic biology workflow. The spirit ofgenetic engineering to focus on whole systems of genes
and gene products is extended by synthetic biology which analyzes biological
organisms in their entirety.

Metabolic
flux analysis and metabolic models

Metabolic
network simulation

Genome-scale
modelling & flux balance analysis

Genetic
architecture of human metabolome

In silico
design of novel pathways

Signal
transduction

Computational
data analysis in metabolomics

Metabolite
biomarker testing and clinical translation

Track 14:
Metabolomic Devices

Metabolomic devices is also called as Metabolomic Tricorder which analyzes blood, urine and
saliva samples for their metabolites- chemical compounds produced within the
body. In addition to aiding diagnoses, it is also prognosticative opening the
possibility of treating predispositions to illnesses such as colorectal cancer,
diabetes and pre-eclampsia. Direct quantitative estimations of metabolite expressionsin serum, pee, plasma, and tissue are
crucial for the investigation of typical illness. Atomic attractive
reverberation (NMR) spectroscopy is especially capable for focused
investigation since it is quantitative, reproducible. Thermo Fisher, AB SCIEX, and Bruker likewise offer instruments for
imaging MS, additionally called MALDI imaging. searchability and information
reconciliation, the metabolomics group has a few activities to build up
information vaults. Cases are Metabolights in the United Kingdom, bolstered by
the European COSMOS (COordination of Standards in MetabOlomicS) consortium that
is creating metabolomics information norms, and Metabolomics Workbench, which
means to be the database for NIH-subsidized metabolomics ventures.

Metabolomics can be used to facilitate lead
compound discovery, to improve biomarker identification and to monitordrug metabolism and toxicityincluding the use of metabolomics to facilitate clinical
trial testing and to improve post-approval drug monitoring. Recent advances in
metabolomics technologies are growing number of mainstream biomedical
applications and metabolomic devices. Metabolomics provides chemical snapshot
of a cell in terms of molecular components of specific cellular processes. It’s
a way to compare cells under different conditions such as healthy versus
diseased. Diseases results in metabolic changes. Metabolomics is being used
in Drug Discoveryand in development from lead compound
discovery to post approval drug surveillance. A consequence of disease leads to
metabolic changes which causes disease advancement. Metabolomics can help in
finding potential new sites for therapeutic intervention by identifying
metabolic changes and provide activity information about possible novel drugs
and drug scaffolds, indicate interesting targets for drug
development, suggests binding partners of compounds. Furthermore, it can
enhance the discovery and testing of new drugs and provide insight into the on-
and off-target effects of drugs.

Toxicology
and drug metabolism

QSAR and
ligand-receptor models

Drug
metabolism during drug design and development

Metabolites
in identification of drug targets

Metabonomics
in preclinical pharmaceutical discovery and development

Applications
in drug development

Track 16: Transcriptomics and
Proteomics

Transcriptomicstudies measure the simultaneous expression
of approximately thousands of genes and can be used to recognize which genes
are up or down regulated under certain conditions. Metabolomic studiesprovide information on the metabolites
found within a biological sample. These two branches seek to uncover the
underlying systems biologyand when combined they can be successful in
predicting gene functions or identifying gene metabolite associations. Proteomicsrefers to study of large scale proteomes.
Proteome is a set of proteins produced in an organism or biological
environment. One of the Systems Biology’s important objectives is to understand
the regulation of cell behavior. And important approaches involve are Measure
of transcriptomic profiles through microarrays, RNA sequence etc. and measure
of proteomic profiles through techniques such as gel electrophoresis and mass spectrometry.

Gene
Expression Profiling and Epigenetics

Next
generation sequencing (NGS) technologies

RNA-seq
technology

Transcriptome
and proteome analysis

RNAi gene
silencing technology

Metabolomics
and phytochemical genomics

Structural
biology

Integration
of proteomics and systems approaches

Signalling
pathways

Identification
of metabolites using high resolution

Track 17: Metabolomics &
biotechnology

Biotechnology, including genetic modification, is a
very principle approach to regulate the production of metabolites in
plants to improve their adaptation to environmental stress, to increase crop
yield and to improve food quality. Metabolomics plays a key role in plant molecular
biotechnology, where plant cells are modified by the expression of engineered
genes, because we can obtain information on the metabolic status of cells via a
snapshot of their metabolome.By concentrate the total arrangement of
metabolites inside a microorganism and checking its correlation between its
advancement forms and the earth, metabolomics can conceivably give a more
precise photo of the actual physiological condition of the cell. Microbial metabolomics has gotten much consideration as of
late essentially in light of the fact that it backings and supplements an
extensive variety of microbial research zones from new medication disclosure
aspires to metabolic building.

Application
of microbial metabolomics

Microbial
metabolomics with higher throughput

Custom
made separation for microbial metabolomics

Track 18: Metabolomic &
pharmacology

Pharmacogenomicshas some effect in clinical practice,
through its utilization to choose tolerant subgroups that will recognize
adequacy without reactions when treated with specific antidote. In any case, pharmacogenomics has less
effect than at first anticipated. One explanation behind this is the
manner by which the patients react to sedate medicines and numerous infections
have both ecological and hereditary components.Unadulterated genomics is relatively
incognizant in regards to the ecological components. Metabolomicsintegrate the most advanced approaches to
molecular phenotype system readout and provides the ideal theranostic
technology platform for the discovery of biomarkerpatterns associated with healthy and
diseased states, for use in personalized health monitoring programs and for the
design of individualized interventions.

Implication
of clinical parmocology

Pharmaceutical
research & Metabolomics in the New born

Track 19: Disease-Focused
Research in Metabolomics

A standard case report will be energetic about the
essentialness of the observation being represented. A decent case
report will be clear about the importance of the observation being reported. In
addition to the “evidence of what happened”,single or multiple cases are an important origin for
further and more advanced research on diagnosis, treatment adequacy, reasons
and results of ailment. Case reports may be first to give signs in separating
another infirmity or disagreeable prosperity affect from an introduction. They
are a vital direct source of confirmation in pharmaceuticaland a device regularly utilized as a part
of practice to craft data and create a more extended quest for proof. Case
reports must be authentic, understandable, educational and clinically
interesting to an international audience of surgeons, trainees and researchers
in all surgical subspecialties, as well as clinicians in related fields.

Cardiovascular
diseases

Neurodegenerative
diseases

Metabolomic
diseases

Auto
Immune Diseases Case Reports

Metabolomic
Diseases Case Reports

Clinical
Case reports

Tracks 20: Current Trends and Innovations in
Metabolomics

Metabolomics has
unique advantages in systems biologyand biomarker discovery. The next generation of analysis techniques promises even richer
and more complete analysis capabilities that will enable earlier clinical
diagnosis, drug refinement, and personalized medicine. The advancements
in statistical analysis that are enhancing and improving the performance
of metabolomics is presented along with highlights of some recent successful
applications. The most recent expansion of omics disciplines is
Metabolomics and it has demonstrated quick development in the application to
human wellbeing research in view of real headways in estimation and examination
methods. Metabolomics has one of the preferences in frameworks
science and biomarkerrevelation.
The upcoming age of examination procedures guarantees significantly wealthier
and total investigation abilities that will empower sedate refinement, clinical
analysis and customized drug. The headways in techniques and factual
investigation that are upgrading and enhancing the execution of metabolomics is
introduced alongside features of fruitful applications.

Spatial
metabolomics

Novel
sensors and instrumentation for detecting metabolites

Network
and pathway analysis for metabolomics

Chemical
and structural characterization of new metabolites

Chemometrics,
statistical analysis, and other approaches to data analysis

Computational
MS

Databases

Track 21: Applications Of Metabolomics In
Agriculture And Industry

With the
availability of Omics data originating from sequencing of the plant
genomes, Biological systemsare extremely complicated and knowledge about the synthesis and
regulation of various plant metabolicsubstances has enhanced substantially. Metabolic profilingof crops is popular for assessing plant phenotypes and the
genetic diversity. The ability to recognize & analyse small metabolites
within any type of biological sample provides valuable insights on the cellular
interactions that are occurring at a certain point in time. Such information
has growing gaintful application for disease diagnosis, drug development,
product safety, food production, plant yield and environmental monitoring.

From
experimental design to knowledge extraction

Green
systems biology from single genomes

Genetic
analysis of metabolome

Plant
metabolomics

Identification
of toxins and pollutants

Microbial
metabolomics

Plant-pathogen
interaction metabolomics

Effects
of genetic and environmental perturbations on metabolite levels and fluxes

Phytochemicals
in plants

Market analysis

‘The Future of Metabolomics' gives complete understanding into the
compelling utilization of metabolomics all through drug discovery, preclinical
development and clinical trials. The report also highlights the use of
metabolomics in maximizing and sustaining revenues post-marketing and in the
development of clinical diagnostics.

Scope & Importance:

The emerging techniques of metabolomics make it an ideal tool for new
innovations in the pharmaceutical, preventive healthcare, and agricultural
industries. Discovery of Biomarkers and drug safety screens are two examples
where metabolomics has already proven its mark. In the future, with the
accessibility of personalised metabolomics, we will potentially be able to
track the trends of our own metabolome for personalised precision drugs and
improved treatment strategies. Personalised precisiontreatment is likely to be more
effective than our current medical approaches.

Metabolomics is now being extensively used in pharmaceutical and biotechnologyindustries for biomarker and drug
discovery; pharmaceutical and biotechnology industries are expected to grow at
a high rate in coming years, which is expected to boost the growth of the
market.

The National Institutes of Health (NIH) grants funds
to Metabolomics program. This aims to elevate national capacity in metabolomics
by supporting the development of next generation technologies to enhance the
sensitivity and speed with which specific elements of the cellular metabolome
can be identified and quantified, providing opportunities, rising the
inventions of chemically identifiable metabolites through the synthesis and
availability of high quality reference standards, and by promoting data sharing
and collaboration.

Rise in the number of clinical trials,toxicologicalstudies,
and health awareness for nutritional products, rapid growth of metabolomics
data analysis software and solutions, and use of metabolomics as diagnostic
tool for biomarker, screening of diseases is expected to propel the growth of
this market.

Global Metabolomics Market Share by Countries

Why to attend?

Meet your target market with recent business reports on Metabolomics
which manifests the tremendous growth in market value for metabolomics
technology till 2019. Since metabolomics interrelated with omics sciences
like Genomics,precision Medicine, Proteomics,
Lipidomics and Transcriptomics, it would be a great opportunity for companies
dealing with Analytical instruments useful in these fields. Also, many upcoming
students and researchers can benefit themselves by participating world class
International workshops, symposia during the conference which will be conducted
by experts in their respective fields.

Target Audience:

Metabolomics Instrumentation Technology
Product Manufacturers

Researchers and Scientists

Metabolomics Industry Consulting Firms

Metabolomics Research and Development
(R&D) Companies

Healthcare Institutions

Research Institutes

Market Research and Consulting Firms

Directors/Managers & Business Delegates,

Director of Laboratories, Universities,

Investigators,

Post-Doctoral Fellows,

Students,

Biomedical Research companies

Glance at Market of Metabolomics:

The market is mainly driven by the increasing research funding for
metabolomics from governments and private investors, growing demand for
personalized medicine in the U.S. and Europe, and the increasing need for
toxicology testing. However, low adoption rates and data complexity inhibits
the growth of the metabolomics market to a certain extent. Metabolomics science
is used extensively in biomarker discovery and drug assessment. Thus, the rapid
growth experienced by pharmaceutical and biotechnology industries is assisting
the growth of the metabolomics market.

In 2017, North America was the market leader with a share of ~42% of the
global market, followed by Europe with a share of ~38%. The presence of large
number of analytical equipment manufacturers has contributed significantly to
the North American and European metabolomics market. The growth in this market
is driven by the growing pharmaceutical and biotechnology industries.

The global metabolomics market was valued at $565 million in 2014, and
$1030 million in 2016. and is expected to grow at a CAGR of 14.6% during the
forecast period (2016–2021) to reach $2410 million by 2022.

Statistics which shows growth in importance of Metabolomics :

Statistics of Industries Associated with Metabolomics:

North America was the market leader with a share of ~42% of the global
market, followed by Europe with a share of ~38%. The presence of a large number
of analytical equipment manufacturers has contributed significantly to the
North American and European metabolomics market. However, the Asia-Pacific
region represents a significant growth opportunity for the metabolomics market
during the forecast period of 2014 to 2019. The APAC market is expected to grow
at a CAGR of 23% during the forecast period. The growth in this market is
driven by the growing pharmaceutical and biotechnology industries.

These three centers will receive an estimated $9 million to $10 million
each over the next five years to create resources and initiate research
programs that will ramp up the national metabolomics science capabilities.

Funding to UC San Diego for this project is $6 million over five years,
part of a total investment by the NIH of $51.4 for the metabolomics project.
The awards are supported by the NIH Common Fund.

Mayo Clinic is one of six new federally-funded Comprehensive
Metabolomics centres to support medical research on metabolomics — the study,
at the cellular level, of how molecules are metabolized in the body. The award
from the National Institutes of Health (NIH) is for $8.8 million over five
years.